Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) announced The New England Journal of Medicine has published results from the North American Phase 3 trial evaluating the safety and efficacy of the Company’s novel antibiotic fidaxomicin as a treatment for patients with Clostridium difficile infection (CDI). The Phase 3 trial showed that fidaxomicin significantly reduced recurrence rates and increased global cure rates when compared to vancomycin, the only treatment approved by the U.S. Food and Drug Administration for CDI. The article titled,
Sharps Compliance Corp. (NASDAQ: SMED), a leading full-service provider of cost-effective management solutions for medical waste and unused patient medications, is helping medical and other healthcare professional offices like doctors, dentists, vets, clinics, tattoo studios, and skilled nursing or assisted living facilities save time, money and the environment with a “GREEN” alternative to their traditional medical waste pick-up service.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/sharpsinc/48184/
Qualcomm Incorporated (NASDAQ: QCOM), a leading developer and innovator of advanced wireless technologies, products and services, today announced that it will showcase some of the latest innovations and ideas that are enabling access, control and interaction with the digital world during the GSMA Mobile World Congress 2011 (Booth 8B53, Hall 8), Feb. 14-17 in Barcelona. The Company’s demonstrations will feature next-generation mobile technologies and services designed to drive today’s and the future’s most advanced mobile devices and experiences. Highlights of the exhibit include LTE Advanced, HSPA+ Advanced, augmented reality, devices based on the Snapdragon™ mobile computing platform, WiPower™ and the Internet of Everything Module (IEM) design for enabling the “Internet of Everything.”
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/qualcomm/48665/
Qualcomm Incorporated (NASDAQ: QCOM) today announced that its Snapdragon™ processors are enabling the latest and greatest multimedia experiences in today’s commercial mobile devices, including stereoscopic 3D (S3D) entertainment, 1080p 30fps HD video capture and playback, console-quality gaming and full web browsing with Adobe Flash 10. The newest member of the Snapdragon family, Qualcomm’s APQ8060 dual-CPU processor, powers the HP TouchPad, which HP introduced yesterday.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/qualcomm/48634/
Activision Publishing, Inc. (Nasdaq: ATVI) announced today the worldwide debut of Skylanders Spyro’s Adventure, an entertainment breakthrough for the toy and video game industries. Through an innovative use of technology, the game allows players to transport real-world toys into virtual worlds of adventure through the “Portal of Power™.” These “toys with brains” can come to life inside the game in connection with multiple gaming platforms, as well as on handheld gaming devices, mobile devices and on the web, remembering achievements and level-ups wherever they go. This marks a wholesale change in the interaction between toys and video games, opening up new possibilities and revenue streams for both industries.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/skylandersgame/48523/
Fisher-Price®, Inc., a subsidiary of Mattel, Inc. (Nasdaq: MAT), and Disney Consumer Products rocked the house at New York Toy Fair for the debut of the innovative and engaging Rock Star™ Mickey. more... Last year's hugely popular Dance Star Mickey brought the iconic character to life for a new generation of fans as he soared to the top of kids' wish lists and was among the hottest toys of the holiday season. This year the excitement moves from the dance floor to the rock stage for a truly authentic rock star experience for kids.
Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, will showcase its 3D mammography and other new, ready-to-market technologies in women’s imaging at the 21st Annual National Interdisciplinary Breast Center Conference (NCBC) in Las Vegas, Nevada, March 12-16, 2011. The NCBC is a nonprofit membership organization dedicated to excellence in breast healthcare for the general public.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/hologic/39364/
Solta Medical, Inc. (Nasdaq: SLTM), the pioneer in fractional resurfacing and non-invasive skin tightening, is pleased to serve as a returning sponsor of the Fresh Express Classic™ at TPC Stonebrae. A Nationwide Tour™ event, the Fresh Express Classic will be held from Tuesday, April 12 through Sunday, April 17, at one of best new golf courses in the U.S., with breathtaking views of the San Francisco Bay. The tournament will include a series of on-site events for fans, including a pro-am led by Pro Football Hall of Fame member Jerry Rice to raise more than $250,000 for Bay Area charities. The event will be televised nationally on The Golf Channel.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/fraxel/49682/
EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, announced today that new 10 year data from an international registry-based multi-center study shows 83 percent of patients had no biopsy evidence of disease after treatment with Ablatherm® HIFU, supporting the technology as a standard primary treatment for localized prostate cancer. Study results were presented at the American Urological Association (AUA) 2011 Annual Meeting, Washington, D.C.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/edap/49862/
Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, has announced the first nine U.S. cities for a series of evening events to introduce clinicians to the Selenia Dimensions 2D/3D breast tomosynthesis system and gain hands-on experience with this new technology.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/hologic/50094/
Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) announced today that the U.S. Food and Drug Administration (FDA) has approved the company’s antibacterial drug DIFICID™ (fidaxomicin) tablets for the treatment of Clostridium difficile-associated diarrhea (CDAD) in adults 18 years of age and older. CDAD is a significant medical problem in hospitals and long-term care facilities, and is beginning to emerge in the community among people previously at low risk for the disease. In the largest Phase 3 clinical studies ever conducted in CDAD, DIFICID had clinical response rates at the end of treatment that were non-inferior to oral vancomycin. DIFICID was superior to vancomycin in sustaining clinical response through 25 days beyond the end of treatment. DIFICID is the only FDA-approved antibacterial drug proven to be superior to vancomycin in sustained clinical response for CDAD.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/optimerpharma/50177/
Thirty-six million Americans suffer from migraines, leading to more than $20 billion in medical expenses and costs related to lost productivity each year¹. In recognition of National Migraine Awareness Month and the significant unmet medical needs of migraine patients, Zogenix, Inc. (NASDAQ: ZGNX) is highlighting the importance of selecting the appropriate medication for a patient’s “treatment toolbox” to address specific types of migraine episodes.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/zogenix/50344/
